VWM
GILD icon

VCI Wealth Management’s Gilead Sciences GILD Stock Holding History

VCI Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.19M Buy
+15,683
New +$2.2M 0.61% 31
2024
Q4 		– Sell
-18,070
Closed -$1.51M – 93
2024
Q3 		$1.51M Buy
+18,070
New +$1.38M 0.67% 41

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCI Wealth Management's GILD Position: Q1 2026 in Review

VCI Wealth Management opened a new position in Gilead Sciences (GILD) in Q1 2026: 15,683 shares worth $2.19M. The stake represents 0.61% of the portfolio and ranks #31 among its holdings. This is a return to the name: VCI Wealth Management previously reported a position in GILD as recently as Q3 2024.

VCI Wealth Management first reported a position in GILD in Q3 2024 and has held it in 2 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • VCI Wealth Management held 15,683 shares of Gilead Sciences worth $2.19M as of Q1 2026.
  • Gilead Sciences was a new VCI Wealth Management position in Q1 2026.
  • Gilead Sciences made up 0.61% of VCI Wealth Management's portfolio in Q1 2026, its #31 holding.
  • VCI Wealth Management first reported a position in Gilead Sciences in Q3 2024 and has held it in 2 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on VCI Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.